Rheumatology

Top Story

Ixekizumab plus background drugs bested background drugs alone in axial SpA

Ixekizumab plus background drugs bested background drugs alone in axial SpA
November 21, 2019
Meeting News

Intervention bundle improves flu vaccination rates in RA/JIA patients

November 21, 2019
ATLANTA — An intervention bundle reminding patients with rheumatoid arthritis and juvenile idiopathic arthritis of the benefits of influenza vaccination was…
Meeting News

Experts create algorithm for management of cutaneous manifestations in lupus

November 20, 2019
Researchers compiled a treatment algorithm for cutaneous manifestations of lupus erythematosus based on data from 104 studies, according to a study presented at the…
Meeting News

Upadacitinib improves signs, symptoms in patients with active AS

November 20, 2019
ATLANTA — A daily regimen of 15 mg upadacitinib was significantly more effective than placebo in improving signs, symptoms, function and imaging among patients…
In the Journals

PsA diagnosis often delayed in dermatology vs. rheumatology

November 20, 2019
In the dermatology setting, researchers found a substantial delay from symptom onset to a psoriatic arthritis diagnosis compared with rheumatology, according to LOOP, a…
More Headlines »
CME ABIM MOC

Ace the Case: A 38-Year-Old Man With a Red and Painful Right Eye

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the diagnosis and management of a 38-year-old man with a…
More »
Video
Meeting News

Patients not receiving needed treatments a 'crisis in osteoporosis'

June 5, 2019
More »
Resource Centers
American College of Rheumatology Annual Meeting

American College of Rheumatology Annual Meeting

CME ABIM MOC

3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - Best Of!

This activity is supported by educational grants from AbbVie, Inc.; Amgen Inc.; Bristol-Myers Squibb; Genentech, Inc.; GlaxoSmithKline; Lilly USA, LLC; Merck & Co., Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Immune-mediated inflammatory diseases (IMIDs) are a group of clinically heterogeneous disorders, including rheumatoid…
More »
Current Issues
View the Current Issue
Healio Rheumatology